Providing daily analysis of the latest earnings reports from US companies to help you make informed investment decisions.

TMO Latest Report

Earnings AnalystFriday, Jan 31, 2025 9:02 am ET

1min read

TMO --

Performance Review

Thermo Fisher (TMO) reported an operating revenue of $11.395 billion as of December 31, 2024, up approximately 4.83% YoY. Despite the revenue growth, the growth rate is still insufficient compared to the industry average, which may be related to the intensified market competition and the decline in its market share. Overall, the company's operating revenue reflects the positive impact of market demand and product innovation.

Key Financial Data

1. The operating revenue in 2024 was $11.395 billion, up 4.83% YoY from $10.886 billion in 2023.

2. 20 new products were launched in 2024, covering life sciences, analytical testing, etc., showing the company's R&D capabilities and market adaptability.

3. The cumulative revenue in the first three quarters of 2024 was $31.484 billion, down 1.52% YoY, indicating a decline in market share.

4. The overall market growth rate in the industry is expected to be between 5%-7%, and Thermo Fisher's growth is slightly lower than the industry average.

Peer Comparison

1. Industry-wide analysis: The biotechnology and medical equipment industry is generally driven by population aging and rising health awareness, with growing market demand. According to industry forecasts, the annual growth rate of this industry in 2024 is between 5%-7%, creating a good market environment.

2. Peer evaluation analysis: Thermo Fisher's operating revenue grew by 4.83%, slightly lower than the industry average. Its competitors such as Abbott and Johnson & Johnson also reported similar revenue growth, indicating that the overall market environment is favorable for all companies. Thermo Fisher needs to strengthen marketing and product innovation to maintain its market share.

Summary

Thermo Fisher achieved revenue growth in 2024, showing a certain market competitiveness and product demand, but the revenue growth rate is lower than the industry average, indicating market share pressure. The company performed positively in launching new products and increasing market demand, but needs to pay attention to the intensified market competition and its own market share changes.

Opportunities

1. New product launch: Thermo Fisher launched several innovative products in 2024, which can enhance market competitiveness.

2. Industry growth potential: The overall growth of the biotechnology and medical equipment industry provides good market opportunities for the company.

3. Expansion of customer base: Through effective marketing strategies, Thermo Fisher can further expand its customer base and increase sales.

Risks

1. Decline in market share: The market share has decreased in 2024, and competitors' pressure needs to be paid attention to.

2. Intensified industry competition: Strong competitors in the industry may affect the company's future revenue growth.

3. Volatility in international markets: If the company relies on international markets, exchange rate fluctuations may affect revenue.

Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.